COVID-19 and liver disease: Are we missing something?  

作　　者：Tarana Gupta 

机构地区：[1]Department of Medicine,Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences,Rohtak 124001,Haryana,India

出　　处：《World Journal of Hepatology》2022年第2期479-481,共3页世界肝病学杂志（英文版）（电子版）

摘　　要：Since the coronavirus disease 2019(COVID-19)has hit the world as a pandemic,researchers all over the world have worked on its diagnostics,prognosticating factors,etc.The present study showed liver enzymes,especially aspartate aminotransferase(AST)levels,to be high in non-survivors with raised AST/alanine aminotransferase ratio.Considering the non-specific nature of AST with its presence in organs other than liver such as muscle,heart,kidney and brain makes it difficult to interpret.Even pre-existing metabolic syndrome and non-alcoholic fatty liver disease are confounding factors for deranged liver functions detected during COVID-19 disease.Therefore,the results of the study should be taken with caution.

关 键 词：COVID-19 Liver disease TRANSAMINASES Non-alcoholic fatty liver disease HEPATOCYTES CHOLANGIOCYTES 

分 类 号：R563.1[医药卫生—呼吸系统] R575[医药卫生—内科学]